Latest Cancer: Skin news
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma
posted June 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
posted June 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Second Primary Malignancy Risk Increased After Cutaneous B-Cell Lymphoma
posted April 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
AI Tool Trained on Dermoscopy Images Helps ID Skin Cancer 
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
1 in 3 Women and 1 in 4 Men Engage in Intentional Outdoor Tanning 
Deep Learning Ensemble Shows Potential for Identifying Melanoma 
Study Explores the Etiology of Melanoma Associated With Tanning Bed Usage 
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma 
Skin Cancer Risk Reduced for Patients Treated With Nicotinamide Monthly Specialist Briefings
Stay Connected
